Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The following presentations were recorded for the virtual Multiple Myeloma Patient Education Symposium, hosted by Dana-Farber Cancer Institute. A live Q&A session will be held via Zoom on January 29, 2022, at 11:00 ET. Please submit questions by January 25 to email@example.com .
A Patient's Perspective: James Bond and wife Kathleen BondJames Bond shares his experience being diagnosed with, treated for, and living with multiple myeloma, and his wife Kathleen shares her tips for being a caregiver for a multiple myeloma patient.
Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MDKen Anderson, MD, discusses current and future treatment options for multiple myeloma patients.
Early Detection and Interception in Multiple Myeloma: Irene Ghobrial, MDIrene Ghobrial, MD, explains efforts to detect and manage multiple myeloma precursor conditions such as MGUS and smoldering multiple myeloma, in order to identify these conditions early and prevent progression to multiple myeloma..
Multiple Myeloma 101: Diagnosis, Prognosis and Risk In Multiple Myeloma: Nikhil C. Munshi, MDNikhil Munshi, MD, provides an overview of multiple myeloma, how it is diagnosed, its risk stratification and prognosis.
Current and Future Directions for Novel and Next Generation Therapy in the Management of Multiple Myeloma: A Clinical Perspective: Paul G. Richardson, MDPaul Richardson, MD, shares insight on new therapies and new approaches for treating multiple myeloma.
The Evolving Role of Quadruplet Therapy in the Management of Newly Diagnosed Multiple Myeloma: Jacob Laubach, MD, MPPJacob Laubach, MD, MPP, presents on quadruplet therapy for newly diagnosed multiple myeloma patients, reviewing the recent GRIFFIN clinical trial and sharing promising future directions.
Updates on Managing Bone Disease in Multiple Myeloma: Monique Hartley-Brown, MD, MMScIn this video, Monique Hartley-Brown, MD, MMSc, provides updates on managing bone disease for multiple myeloma patients.
COVID-19 and Multiple Myeloma: Clifton Mo, MDIn this video, Clifton Mo, MD, discusses COVID-19, COVID-19 vaccines and treatments, and their impact on multiple myeloma patients.
Symptom Management in Multiple Myeloma: Shonali Midha, MDShonali Midha, MD, discusses ways to address symptoms multiple myeloma patients may have as a result of their disease or their treatment.
Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, When and How?: Omar Nadeem, MDIn this presentation, Omar Nadeem, MD, considers the role of bispecific antibodies and CAR T-cell therapy in multiple myeloma treatment.
CAR T-Cells in Multiple Myeloma: Adam Sperling, MD, PhDAdam Sperling, MD, PhD, provides an update on BCMA CAR T cells and shares a preview of next steps in CAR T development for multiple myeloma.
Updates on AL Amyloidosis Treatment: What Is New in 2022: Giada Bianchi, MDIn this presentation, Giada Bianchi, MD, discusses recent advances in the treatment of AL amyloidosis, a plasma cell disorder.
New Patient Appointments
For adults: 877-442-3324For children: 888-733-4662
Learn more about Dana-Farber's Multiple Myeloma Program